Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics Study on IL28B Genetic Variants for Prediction of Drug Response in Chinese Children With HCV Infection.

NCT01607021 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT01607021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01607021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics Study on IL28B Genetic Variants for Prediction of Drug Response in Chinese Children With HCV Infection.
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2012
Completion date
December 31, 2015
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c